I agree that this site is using cookies. You can find further informations here.
X
Gallogly, Molly M.
~ 100  results:
Search for persons X
?
1

A Phase II Study of Midostaurin and 5-Azacitidine for Untre..:

Tomlinson, Benjamin K. ; Gallogly, Molly M. ; Kane, Donna M....
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  4 - p. 226-233.e1 , 2020
Link: https://doi.org/10.1016/..
 
?
2

Midostaurin: a novel therapeutic agent for patients with FL..:

Gallogly, Molly M. ; Lazarus, Hillard M. ; Cooper, Brenda W.
Therapeutic Advances in Hematology.  8 (2017)  9 - p. 245-261 , 2017
Link: https://doi.org/10.1177/..
 
?
3

Covalent Cross-Linking of Glutathione and Carnosine to Prot..:

Zhu, Xiaochun ; Gallogly, Molly M. ; Mieyal, John J...
Chemical Research in Toxicology.  22 (2009)  6 - p. 1050-1059 , 2009
Link: https://doi.org/10.1021/..
 
?
4

Kinetic and Mechanistic Characterization and Versatile Cata..:

Gallogly, Molly M. ; Starke, David W. ; Leonberg, Amanda K...
Biochemistry.  47 (2008)  42 - p. 11144-11157 , 2008
Link: https://doi.org/10.1021/..
 
?
5

Mechanisms of reversible protein glutathionylation in redox..:

Gallogly, Molly M ; Mieyal, John J
Current Opinion in Pharmacology.  7 (2007)  4 - p. 381-391 , 2007
Link: https://doi.org/10.1016/..
 
?
6

Potential Consequences of Age‐Dependent Changes in Glutared..:

Pai, Harish V. ; Gallogly, Molly M. ; Starke, David W....
The FASEB Journal.  21 (2007)  6 - p. , 2007
Link: https://doi.org/10.1096/..
 
?
7

Midostaurin: a novel therapeutic agent for patients with FL..:

Gallogly, Molly M ; Lazarus, Hillard M ; Cooper, Brenda W
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639976/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
8

Glutaredoxin Regulates Apoptosis in Cardiomyocytes via NFκB..:

Gallogly, Molly M ; Shelton, Melissa D ; Qanungo, Suparna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864653.  , 2010
Link: http://www.ncbi.nlm.nih...
 
?
9

Mechanistic and Kinetic Details of Catalysis of Thiol-Disul..:

Gallogly, Molly M ; Starke, David W ; Mieyal, John J
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2842129.  , 2009
Link: http://www.ncbi.nlm.nih...
 
?
10

Covalent Cross-Linking of Glutathione and Carnosine to Prot..:

Zhu, Xiaochun ; Gallogly, Molly M ; Mieyal, John J..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857574.  , 2009
Link: http://www.ncbi.nlm.nih...
 
?
11

Kinetic and Mechanistic Characterization and Versatile Cata..:

Gallogly, Molly M ; Starke, David W ; Leonberg, Amanda K..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569056.  , 2008
Link: http://www.ncbi.nlm.nih...
 
?
12

Molecular Mechanisms and Clinical Implications of Reversibl..:

Mieyal, John J ; Gallogly, Molly M ; Qanungo, Suparna..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2774718.  , 2008
Link: http://www.ncbi.nlm.nih...
 
?
13

Targeted Marrow Irradiation Intensification of Reduced-Inte..:

Ali, Naveed ; Sharma, Ashish Arunkumar ; de Rezende, Ana Carolina Pires...
Transplantation and Cellular Therapy.  28 (2022)  7 - p. 370.e1-370.e10 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Clostridioides Difficile Infection Prophylaxis in Allogenei..:

Patel, Seema ; Copley, Melissa ; Boughan, Kirsten M...
Transplantation and Cellular Therapy.  27 (2021)  3 - p. S362 , 2021
Link: https://doi.org/10.1016/..
 
?
15

Aggressive lymphoma subtype is a risk factor for venous thr..:

Dharmavaram, Gouri ; Cao, Shufen ; Sundaram, Suchitra...
American Journal of Hematology.  95 (2020)  8 - p. 918-926 , 2020
Link: https://doi.org/10.1002/..
 
1-15